Back on the move for V2All hurdles cleared and clinic trails a go. Like the fact they are doing a larger sample on actual patients, compared to PCR. If HC won't test on live virus, then we can now roll up and hand them a large sample (5X bigger than the Saudivax one), taken on real people, exactly how the thing is supposed to work. Plus it is on symptomatic patients, Sona's swab seem great on early, asymptomatic cases, so hopefully they knock it out of the park on symptomatic.
So it will all come down to trial results and we see if this is a home run or not. I am optomisitc on it (but no proof or inside info or any of that stuff), as I beleive if they were not getting good results on it, why spend all this $ go through the hassel for the trial and all the while insiders are hanging tight. So no pump and dump (heck, not a peep out of them until now, let alone any pump). So let's get those results.
Buckle up.
GLTA.